Mitochondrion: An emerging platform critical for host antiviral signaling

Expert Opinion on Therapeutic Targets

Volumn 15, Issue 5, 2011, Pages 647-665

  Wang, Chen ^a   Liu, Xinyi ^a   Wei, Bo ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Antiviral signal transduction; IKK; inflammation; innate immunity; IRF3; MAVS IPS 1 Cardif VISA; mitochondria; NF kB; RIG I; TBK1; Tom70

Indexed keywords

ADAPTOR PROTEIN; ALPHA INTERFERON; BETA INTERFERON; HEAT SHOCK PROTEIN 90; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; INTERFERON STIMULATED GENE FACTOR 3; INTERLEUKIN 1; MITOCHONDRIAL ANTIVIRAL SIGNALLING PROTEIN; MITOCHONDRIAL PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; RETINOIC ACID INDUCIBLE PROTEIN I; RETINOIC ACID INDUCIBLE PROTEIN I LIKE RECEPTOR; RETINOIC ACID RECEPTOR; RNA HELICASE; SMALL INTERFERING RNA; STAT PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 20; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS ANTIBODY;

ADAPTIVE IMMUNITY; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; AUTOPHAGY; BIOCHEMISTRY; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL ORGANELLE; CYLINDROMA; CYTOPLASM; CYTOSOL; DEGENERATIVE DISEASE; DIMERIZATION; ENCEPHALOMYOCARDITIS VIRUS; ENDOPLASMIC RETICULUM; ENDOSOME; ENZYME MECHANISM; ENZYME REGULATION; FIBROBLAST; GOLGI COMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HYDROLYSIS; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION PREVENTION; INFLAMMATION; INFLUENZA VIRUS A; INHIBITION KINETICS; INNATE IMMUNITY; INTERFERON PRODUCTION; JAPANESE ENCEPHALITIS VIRUS; LIPID METABOLISM; MAMMAL CELL; MENGO VIRUS; MITOCHONDRION; NONHUMAN; OLIGOMERIZATION; OUTER MEMBRANE; PARAMYXOVIRUS; PHOSPHORYLATION; PICORNAVIRUS; PLASMACYTOID DENDRITIC CELL; POLIOMYELITIS; PROTEIN BINDING; PROTEIN HOMEOSTASIS; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REOVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RNA VIRUS INFECTION; SENDAI VIRUS; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TETRATRICOPEPTIDE REPEAT; UBIQUITINATION; VESICULAR STOMATITIS VIRUS; VIRAL CLEARANCE; VIRUS INHIBITION; VIRUS MUTATION; VIRUS REPLICATION;

ANIMALS; DEAD-BOX RNA HELICASES; HUMANS; IMMUNITY, INNATE; MITOCHONDRIAL PROTEINS; NF-KAPPA B; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 79954567793     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.2011.561321     Document Type: Review

References (131)

1. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007;449:811-18 (Pubitemid 47598621)
2. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007;449:819-26 (Pubitemid 47598622)
3. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002;296:298-300 (Pubitemid 34303673)
4. Bowie AG, Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 2008;8:911-22
5. Katze MG, He Y, Gale M Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002;2:675-87 (Pubitemid 37328725)
6. Unterholzner L, Keating SE, Baran M, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010;11:997-1004
7. Takaoka A, Wang Z, Choi MK, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007;448:501-5 (Pubitemid 47123520)
8. Hornung V, Ablasser A, Charrel-Dennis M, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009;458:514-18
9. Fernandes-Alnemri T, Yu JW, Datta P, et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009;458:509-13
10. Burckstummer T, Baumann C, Bluml S, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009;10:266-72
11. Roberts TL, Idris A, Dunn JA, et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 2009;323:1057-60
12. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-84
13. Sun Q, Sun L, Liu HH, et al. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 2006;24:633-42 (Pubitemid 43728147)
14. Moore CB, Ting JP. Regulation of mitochondrial antiviral signaling pathways. Immunity 2008;28:735-9 (Pubitemid 351778413)
15. AblasserA, Bauernfeind F, Hartmann G, et al. RIG-I-dependent sensing of poly (dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009;10:1065-72
16. Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009;138:576-91
17. Takeuchi O, Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008;20:17-22
18. Yoneyama M, Fujita T. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 2008;29:178-81
19. Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 2005;6:981-8 (Pubitemid 41486182)
20. Meylan E, Curran J, Hofmann K, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005;437:1167-72 (Pubitemid 41509355)
21. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF3. Cell 2005;122:669-82 (Pubitemid 41242633)
22. Xu LG, Wang YY, Han KJ, et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005;19:727-40
23. Saha SK, Pietras EM, He JQ, et al. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif EMBO J 2006;25:3257-63 (Pubitemid 44141784)
24. Liu XY, Wei B, Shi HX, et al. Tom70 mediates activation of interferon regulatory factor 3 on mitochondria. Cell Res 2010;20:994-1011
25. Tang ED, Wang CY. TRAF5 is a downstream target of MAVS in antiviral innate immune signaling. PLoS One 2010;5:e9172
26. Zhao T, Yang L, Sun Q, et al. The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways. Nat Immunol 2007;8:592-600 (Pubitemid 46785123)
27. Guo B, Cheng G. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 2007;282:11817-26 (Pubitemid 47100710)
28. Li XD, Sun L, Seth RB, et al. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci USA 2005;102:17717-22 (Pubitemid 41803563)
29. Gray MW, Burger G, Lang BF. Mitochondrial evolution. Science 1999;283:1476-81
30. McBride HM, Neuspiel M, Wasiak S. Mitochondria: more than just a powerhouse. Curr Biol 2006;16:R551-60 (Pubitemid 44066793)
31. Castanier C, Arnoult D. Mitochondrial localization of viral proteins as a means to subvert host defense. Biochim Biophys Acta 2010; published online 31 August 2010, doi:101016/jbbamcr201008009
32. Andrejeva J, Childs KS, Young DF, et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 2004;101:17264-9 (Pubitemid 39627808)
33. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004;5:730-7 (Pubitemid 39023305)
34. Yoneyama M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005;175:2851-8 (Pubitemid 41170502)
35. Zeng W, Xu M, Liu S, et al. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol Cell 2009;36:315-25
36. Lin R, Lacoste J, Nakhaei P, et al. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKε molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 2006;80:6072-83 (Pubitemid 43849185)
37. Paz S, Vilasco M, Arguello M, et al. Ubiquitin-regulated recruitment of IκB kinase η to the MAVS interferon signaling adapter. Mol Cell Biol 2009;29:3401-12
38. Yang K, Shi H, Qi R, et al. Hsp90 regulates activation of interferon regulatory factor 3 and TBK-1 stabilization in Sendai virus-infected cells. Mol Biol Cell 2006;17:1461-71 (Pubitemid 43376563)
39. Neupert W, Herrmann JM. Translocation of proteins into mitochondria. Annu Rev Biochem 2007;76:723-49
40. Young JC, Hoogenraad NJ, Hartl FU. Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70. Cell 2003;112:41-50 (Pubitemid 36106417)
41. Wu Y, Sha B. Crystal structure of yeast mitochondrial outer membrane translocon member Tom70p. Nat Struct Mol Biol 2006;13:589-93 (Pubitemid 44036468)
42. Millar DG, Shore GC. Mitochondrial Mas70p signal anchor sequence. Mutations in the transmembrane domain that disrupt dimerization but not targeting or membrane insertion. J Biol Chem 1994;269:12229-32
43. Pearl LH, Prodromou C, Workman P. The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem J 2008;410:439-53 (Pubitemid 351429015)
44. Tang ED, Wang CY. MAVS self-association mediates antiviral innate immune signaling. J Virol 2009;83:3420-8
45. Baril M, Racine ME, Penin F, Lamarre D. MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease. J Virol 2009;83:1299-311
46. Sadler AJ, Williams BR Interferon-inducible antiviral effectors. Nat Rev Immunol 2008;8:559-68
47. Komuro A, Horvath CM. RNA-and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J Virol 2006;80:12332-42 (Pubitemid 44904383)
48. Venkataraman T, Valdes M, Elsby R, et al. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol 2007;178:6444-55 (Pubitemid 46717428)
49. Satoh T, Kato H, Kumagai Y, et al. LGP2 is a positive regulator of RIG-I-and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA 2010;107:1512-17
50. Oshiumi H, Sakai K, Matsumoto M, Seya T. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential. Eur J Immunol 2010;40:940-8
51. Wang YY, Liu LJ, Zhong B, et al. WDR5 is essential for assembly of the VISA-associated signaling complex and virus-triggered IRF3 and NF-κB activation. Proc Natl Acad Sci USA 2010;107:815-20
52. Moore CB, Bergstralh DT, Duncan JA, et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008;451:573-7 (Pubitemid 351186265)
53. Arnoult D, Soares F, Tattoli I, et al. An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. J Cell Sci 2009;122:3161-8
54. Cui J, Zhu L, Xia X, et al. NLRC5 negatively regulates the NF-κB and type I interferon signaling pathways. Cell 2010;141:483-96
55. Kumar H, Pandey S, Zou J, et al. NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections. J Immunol 2011;186:994-1000
56. Yasukawa K, Oshiumi H, Takeda M, et al. Mitofusin 2 inhibits mitochondrial antiviral signaling. Sci Signal 2009;2:ra47
57. Onoguchi K, Onomoto K, Takamatsu S, et al. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 2010;6:e1001012
58. Castanier C, Garcin D, Vazquez A, Arnoult D. Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway. EMBO Rep 2010;11:133-8
59. You F, Sun H, Zhou X, et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat Immunol 2009;10:1300-8
60. de Brito OM, Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008;456:605-10
61. Sun W, Li Y, Chen L, et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc Natl Acad Sci USA 2009;106:8653-8
62. Zhong B, Yang Y, Li S, et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 2008;29:538-50
63. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008;455:674-8
64. Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009;461:788-92
65. Saitoh T, Fujita N, Hayashi T, et al. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci USA 2009;106:20842-6
66. Zhong B, Zhang L, Lei C, et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 2009;30:397-407
67. Tsuchida T, Zou J, Saitoh T, et al. The Ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 2010;33:765-76
68. Li Y, Li C, Xue P, et al. ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response. Proc Natl Acad Sci USA 2009;106:7945-50
69. Jounai N, Takeshita F, Kobiyama K, et al. The Atg5-Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci USA 2007;104:14050-5 (Pubitemid 350003333)
70. Dixit E, Boulant S, Zhang Y, et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 2010;141:668-81
71. Song T, Wei C, Zheng Z, et al. c-Abl tyrosine kinase interacts with MAVS and regulates innate immune response. FEBS Lett 2010;584:33-8
72. Johnsen IB, Nguyen TT, Bergstroem B, et al. The tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling. J Biol Chem 2009;284:19122-31
73. Vitour D, Dabo S, Ahmadi Pour M, et al. Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS. J Biol Chem 2009;284:21797-809
74. Gack MU, Shin YC, Joo CH, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007;446:916-20 (Pubitemid 46633167)
75. Gack MU, Kirchhofer A, Shin YC, et al. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc Natl Acad Sci USA 2008;105:16743-8
76. Shigemoto T, Kageyama M, Hirai R, et al. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J Biol Chem 2009;284:13348-54
77. Oshiumi H, Matsumoto M, Hatakeyama S, Seya T. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J Biol Chem 2009;284:807-17
78. Gao D, Yang YK, Wang RP, et al. REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS One 2009;4:e5760
79. Arimoto K, Takahashi H, Hishiki T, et al. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci USA 2007;104:7500-5 (Pubitemid 47185935)
80. Arimoto K, Konishi H, Shimotohno K. UbcH8 regulates ubiquitin and ISG15 conjugation to RIG-I. Mol Immunol 2008;45:1078-84 (Pubitemid 350016330)
81. Friedman CS, O'Donnell MA, Legarda-Addison D, et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 2008;9:930-6
82. Zhang M, Wu X, Lee AJ, et al. Regulation of IκB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem 2008;283:18621-6
83. Kayagaki N, Phung Q, Chan S, et al. DUBA: a deubiquitinase that regulates type I interferon production. Science 2007;318:1628-32 (Pubitemid 350233662)
84. Boone DL, Turer EE, Lee EG, et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004;5:1052-60 (Pubitemid 41057725)
85. Wertz IE, O'Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 2004;430:694-9 (Pubitemid 39061687)
86. Lin R, Yang L, Nakhaei P, et al. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J Biol Chem 2006;281:2095-103 (Pubitemid 43845798)
87. Saitoh T, Yamamoto M, Miyagishi M, et al. A20 is a negative regulator of IFN regulatory factor 3 signaling. J Immunol 2005;174:1507-12
88. Parvatiyar K, Barber GN, Harhaj EW. TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J Biol Chem 2010;285:14999-5009
89. Nakhaei P, Mesplede T, Solis M, et al. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog 2009;5:e1000650
90. Jia Y, Song T, Wei C, et al. Negative regulation of MAVS-mediated innate immune response by PSMA7. J Immunol 2009;183:4241-8
91. Yang K, Shi HX, Liu XY, et al. TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J Immunol 2009;182:3782-92
92. Mao AP, Li S, Zhong B, et al. Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. J Biol Chem 2010;285:9470-6
93. Li S, Zheng H, Mao AP, et al. Regulation of virus-triggered signaling by OTUB1-and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J Biol Chem 2010;285:4291-7
94. Chen R, Zhang L, Zhong B, et al. The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. Cell Res 2010;20:802-11
95. Kim MJ, Hwang SY, Imaizumi T, Yoo JY. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol 2008;82:1474-83
96. Zhao C, Denison C, Huibregtse JM, et al. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 2005;102:10200-5 (Pubitemid 41023349)
97. Shi HX, Yang K, Liu X, et al. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol 2010;30:2424-36
98. Skaug B, Chen ZJ. Emerging role of ISG15 in antiviral immunity. Cell 2010;143:187-90
99. Mi Z, Fu J, Xiong Y, Tang H. SUMOylation of RIG-I positively regulates the type I interferon signaling. Protein Cell 2010;1:275-83
100. Kubota T, Matsuoka M, Chang TH, et al. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. J Biol Chem 2008;283:25660-70
101. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003;552:335-44 (Pubitemid 37321833)
102. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4:181-9 (Pubitemid 38339084)
103. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004;2:820-32 (Pubitemid 39317463)
104. Tattoli I, Carneiro LA, Jehanno M, et al. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-κB and JNK pathways by inducing reactive oxygen species production. EMBO Rep 2008;9:293-300 (Pubitemid 351330996)
105. Gack MU, Nistal-Villan E, Inn KS, et al. Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J Virol 2010;84:3220-9
106. Nistal-Villan E, Gack MU, Martinez-Delgado G, et al. Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production. J Biol Chem 2010;285:20252-61
107. Li K, Foy E, Ferreon JC, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005;102:2992-7 (Pubitemid 40299904)
108. Chen Z, Benureau Y, Rijnbrand R, et al. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 2007;81:964-76 (Pubitemid 46067921)
109. Rebsamen M, Meylan E, Curran J, Tschopp J. The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ 2008;15:1804-11
110. Yang Y, Liang Y, Qu L, et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci USA 2007;104:7253-8 (Pubitemid 47186041)
111. Lei X, Liu X, Ma Y, et al. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 2010;84:8051-61
112. Mibayashi M, Martinez-Sobrido L, Loo YM, et al. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 2007;81:514-24 (Pubitemid 46067878)
113. Dauber B, Schneider J, Wolff T. Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. J Virol 2006;80:11667-77 (Pubitemid 44788880)
114. Ling Z, Tran KC, Teng MN. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J Virol 2009;83:3734-42
115. Iwai A, Shiozaki T, Kawai T, et al. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem 2010;285:32064-74
116. Wei C, Ni C, Song T, et al. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol 2010;185:1158-68
117. Wang X, Li Y, Mao A, et al. Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-beta induction by disrupting the VISA-associated complex. Cell Mol Immunol 2010;7:341-8
118. Wang H, Ryu WS. Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog 2010;6:e1000986
119. Yu S, Chen J, Wu M, et al. Hepatitis B virus polymerase inhibits RIG-I-and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKε and DDX3. J Gen Virol 2010;91:2080-90
120. Dong X, Feng H, Sun Q, et al. Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication. PLoS Pathog 2010;6:e1001001
121. Chattopadhyay S, Marques JT, Yamashita M, et al. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J 2010;29:1762-73
122. Lei Y, Moore CB, Liesman RM, et al. MAVS-mediated apoptosis and its inhibition by viral proteins. PLoS One 2009;4:e5466
123. Lin R, Paz S, Hiscott J. Tom70 imports antiviral immunity to the mitochondria. Cell Res 2010;20:971-3
124. Cheng G, Zhong J, Chung J, Chisari FV. Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc Natl Acad Sci USA 2007;104:9035-40 (Pubitemid 47175432)
125. Matzinger P. The danger model: a renewed sense of self. Science 2002;296:301-5 (Pubitemid 34303674)
126. Tveita AA. The danger model in deciphering autoimmunity. Rheumatology (Oxford) 2010;49:632-9
127. Okabe Y, Kawane K, Akira S, et al. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J Exp Med 2005;202:1333-9 (Pubitemid 41668736)
128. Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008;134:587-98
129. Yasutomo K, Horiuchi T, Kagami S, et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001;28:313-14 (Pubitemid 32702418)
130. Lamarre D, Anderson PC, Bailey M, et al. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 2003;426:186-9 (Pubitemid 37442587)
131. Foy E, Li K, Wang C, et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003;300:1145-8 (Pubitemid 36583099)